c-Kit receptor signaling in the modulation of collecting duct function
openNIDDK - National Institute of Diabetes and Digestive and Kidney Diseases
PROJECT SUMMARY
The current proposal is based upon our surprising finding that c-Kit is expressed in the kidney collecting
duct. c-Kit regulates the proliferation and differentiation of stem cells; however, its role in in fully differentiated
epithelial cells, such as in the collecting duct, remains elusive. Thus, this proposal aims to uncover the role of c-
Kit receptor signaling in the modulation of kidney collecting duct function.
The collecting duct is made up of principal cells (PC), which reabsorb water and salt, and intercalated
cells (IC), which secrete protons. The collecting duct epithelial composition is altered in response to biochemical
signals, thus affecting whole-body water, electrolyte and acid-base balance. For example, lithium treatment
promotes PC differentiation into IC. Fewer PC prevents water reabsorption and leads to the development of
nephrogenic diabetes insipidus (NDI), which can lead to severe dehydration and death. However, the precise
mechanism by which epithelial cell fate is determined in the adult kidney collecting duct is not well understood.
To address this question, I intend to utilize c-Kit “Sash” mice carrying the Wsh/Wsh mutation in a
transcriptional element upstream of the KIT gene. This mutation results in reduced c-Kit expression in specific
tissues and cells. I demonstrated for the first time that "Sash" mice have significantly reduced c-Kit expression
in the collecting duct. I found that male “Sash” mice had an abnormally low urine pH, which could be explained
by the fact that these mice have more acid-secreting IC and fewer water-absorbing PC in their collecting ducts.
These findings led me to hypothesize that c-Kit receptor signaling in IC is required to maintain the normal
cellular composition of the collecting duct, thus allowing the kidney to maintain proper extracellular
volume, electrolyte, and acid-base homeostasis.
In the current proposal I will determine: a) which isoforms of c-Kit and its ligand are expressed in the
collecting duct; b) whether loss of c-Kit in the collecting duct affects renal function, and makes mice more
susceptible to NDI, thus, mimicking disease states in the kidney; and c) the gene and protein networks associated
with c-Kit receptor signaling in the kidney collecting duct under baseline and lithium-challenged conditions. Since
c-Kit receptor activity is required for critical cellular processes including hematopoiesis and mast cell function,
universal inhibition of c-Kit is not ideal therapeutically. This makes identifying subpopulations of receptors/ligands
that are expressed in specific cell types or tissues critical to developing targeted therapeutics. Furthermore, my
work will offer new directions for future studies on c-Kit regulation at the basic cell biological level, as well as
providing a novel molecular basis for long-term drug discovery efforts to modulate c-Kit activity in the kidney, and
other organs, to attenuate pathological processes caused by c-Kit receptor dysfunction.
Up to $111K
health research